News

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Pomegranate juice contains potent antioxidants that may help lower blood pressure, although finding are mixed. Learn why and ...
SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...
A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...
A weight-loss doctor is warning patients not to rely on Wegovy as a cure for obesity, saying the newly available medication could be more harmful than helpful.
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.
EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest ...
The number of reported measles cases in the United States has hit 1,288 in the first six months of this year, the most since ...
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.